Edition:
United Kingdom

Erytech Pharma SA (ERYP.PA)

ERYP.PA on Paris Stock Exchange

6.89EUR
2:37pm GMT
Change (% chg)

€-0.22 (-3.03%)
Prev Close
€7.11
Open
€7.26
Day's High
€7.26
Day's Low
€6.68
Volume
52,992
Avg. Vol
45,465
52-wk High
€26.25
52-wk Low
€5.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 2.27 -1.060
FY 2017 Dec '17 1.58 -1.516
Jun '17 1.79 -1.420
FY 2016 Dec '16 1.74 -1.433
Jun '16 2.40 -1.310
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-18 5 5.02 11.00 0.00 4.15
Year Ending Dec-19 5 5.94 13.00 0.00 27.37
Earnings (per share)
Year Ending Dec-18 4 -2.71 -2.25 -3.19 -2.41
Year Ending Dec-19 4 -3.17 -2.35 -3.54 -1.91
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.49 33.64
P/E High - Last 5 Yrs. -- 308.79 45.61
P/E Low - Last 5 Yrs. -- 85.15 23.70
Beta 0.86 0.93 0.88
Price to Sales (TTM) 80.61 121.71 5.95
Price to Book (MRQ) -- 14.77 4.89
Price to Tangible Book (MRQ) -- 13.90 6.50
Price to Cash Flow (TTM) -- 66.81 22.90
% Owned Institutions -- 13.77 2.15

Dividends

  Company industry sector
Dividend Yield -- 0.41 1.51
Dividend Yield - 5 Year Avg -- 0.31 1.52
Dividend 5 Year Growth Rate -- 2.84 5.41
Payout Ratio(TTM) -- 25.52 43.93

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -25.59 387.07 8.08
Sales (TTM) vs TTM 1 Yr. Ago -8.67 97.70 5.80
Sales - 5 Yr. Growth Rate 35.25 29.11 9.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -37.52 27.93 23.27
EPS (TTM) vs TTM 1 Yr. Ago -27.13 -- --
EPS - 5 Yr. Growth Rate -- 33.15 10.88
Capital Spending - 5 Yr. Growth Rate 81.34 36.76 14.85

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.02 2.27
Current Ratio (MRQ) -- 5.29 3.07
LT Debt to Equity (MRQ) -- 36.70 13.15
Total Debt to Equity (MRQ) -- 38.52 17.74
Interest Coverage (TTM) -- -90.95 37.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.86
Gross Margin - 5 Yr. Avg. -- 48.29 52.38
EBITD Margin (TTM) -732.50 -- --
EBITD - 5 Yr. Avg -321.23 -554.66 10.90
Operating Margin (TTM) -736.87 -797.48 3.24
Operating Margin - 5 Yr. Avg. -331.17 -575.64 6.22
Pre-Tax Margin (TTM) -727.19 -760.60 4.31
Pre-Tax Margin - 5 Yr. Avg. -337.58 -581.03 6.66
Net Profit Margin (TTM) -727.87 -761.46 0.58
Net Profit Margin - 5 Yr. Avg. -337.31 -583.67 2.90
Effective Tax Rate (TTM) -- 25.03 23.26
Effective Tax Rate - 5 Yr. Avg. -- 19.86 24.21

Efficiency

  Company industry sector
Revenue/Employee (TTM) 41,447 22,792,305 803,310,395
Net Income/Employee (TTM) -301,682 1,402,730 94,478,415
Receivable Turnover (TTM) -- 19.90 5.78
Inventory Turnover (TTM) -- 2.68 3.71
Asset Turnover (TTM) -- 0.42 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -1.66 10.86
Return on Assets - 5 Yr. Avg. -38.25 2.77 11.96
Return on Investment (TTM) -- -0.29 14.22
Return on Investment - 5 Yr. Avg. -46.07 1.51 15.54
Return on Equity (TTM) -- 0.40 15.99
Return on Equity - 5 Yr. Avg. -51.29 1.96 16.82
  1 Year 3 Year 5 Year
Sales % 41.28 31.92 35.25
EPS (TTM) % -27.20 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Erytech Pharma SA

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -8.30 -12.52 36 58
13 Week -7.07 -10.79 72 61
26 Week -12.20 -15.88 77 74
52 Week 35.52 13.27 99 45
YTD 76.06 59.71 99 56
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 49.65%
# of Holders: 23
Total Shares Held: 8,905,149
3 Mo. Net Change: -1,027,183
# New Positions: 1
# Closed Positions: 3
# Increased Positions: 5
# Reduced Positions: 4
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.